Zobrazeno 1 - 7
of 7
pro vyhledávání: '"T K, Nikula"'
Autor:
R, Senekowitsch-Schmidtke, C, Schuhmacher, K F, Becker, T K, Nikula, C, Seidl, I, Becker, M, Miederer, C, Apostolidis, C, Adam, R, Huber, E, Kremmer, K, Fischer, M, Schwaiger
Publikováno v:
Cancer research. 61(7)
A monoclonal antibody (E-cadherin delta 9-1) directed against a characteristic E-cadherin mutation (in-frame deletion of exon 9), found in diffuse-type gastric cancer but not in any normal tissue, was conjugated with the high linear energy transfer a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5b3912187bea64ff6a978608f8c69a0
https://pubmed.ncbi.nlm.nih.gov/11306447
https://pubmed.ncbi.nlm.nih.gov/11306447
Autor:
T K, Nikula, M R, McDevitt, R D, Finn, C, Wu, R W, Kozak, K, Garmestani, M W, Brechbiel, M J, Curcio, C G, Pippin, L, Tiffany-Jones, M W, Geerlings, C, Apostolidis, R, Molinet, O A, Gansow, D A, Scheinberg
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(1)
The alpha-particle-emitting radionuclides have several physical characteristics that make them attractive candidates for radioimmunotherapy: (a) high linear energy transfer; (b) short path lengths (50-80 microm); and (c) limited ability of cells to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a39d6ace035dc0448a7e18301ec6faa
https://pubmed.ncbi.nlm.nih.gov/9935073
https://pubmed.ncbi.nlm.nih.gov/9935073
Autor:
J G, Jurcic, P C, Caron, T K, Nikula, E B, Papadopoulos, R D, Finn, O A, Gansow, W H, Miller, M W, Geerlings, R P, Warrell, S M, Larson
Publikováno v:
Cancer research. 55
M195, a mouse monoclonal antibody reactive with the early myeloid antigen CD33, has been shown to target leukemia cells in patients and to reduce large leukemic burdens when labeled with 131I. A complementarity-determining region-grafted, humanized v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eda92ffd21cf3b7ee884d5a3fbaea78d
https://pubmed.ncbi.nlm.nih.gov/7493368
https://pubmed.ncbi.nlm.nih.gov/7493368
Autor:
T. K. Nikula, Ronald D. Finn, Monica Bocchia, David A. Scheinberg, Yan Ma, Michael Curcio, George Sgouros
Publikováno v:
Molecular immunology. 32(12)
Although iodine-131 is the most widely used radionuclide for radioimmunotherapy, direct radiolabeling methods yield decreased immunoreactivity of the antibody as a function of increased iodine incorporation. We have studied the amino acid sequences o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482d58131ffadebe62ed1cadcb1adf92
https://pubmed.ncbi.nlm.nih.gov/7565813
https://pubmed.ncbi.nlm.nih.gov/7565813
Autor:
K J, Kairemo, H, Ramsay, T K, Nikula, E V, Hopsu, M J, Taavitsainen, S, Bondestam, J V, Hiltunen
Publikováno v:
Journal of nuclear biology and medicine (Turin, Italy : 1991). 38(4 Suppl 1)
Bleomycin (BLM) is a well known natural antibiotic. It is toxic to dividing cells and has been used for the treatment of several forms of cancer. BLM has been labeled with various cations, but most of them have turned out be unstable in in-vivo exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac5092ec06a9dd1a5d922b75bc319412
https://pubmed.ncbi.nlm.nih.gov/7543289
https://pubmed.ncbi.nlm.nih.gov/7543289
Publikováno v:
Nuclear Medicine Communications. 18:468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1ec278d6a82cf0e710b0729e5457ef9
https://doi.org/10.1097/00006231-199705000-00037
https://doi.org/10.1097/00006231-199705000-00037
Autor:
T. K. Nikula, R. D. Finn, C. Wu, M. Curcio, D. A. Scheinberg, Christos Apostolidis, O. A. Gansow, C. G. Pippin, M. W. Geerlings, R. W. Kozak
Publikováno v:
Journal of Immunotherapy. 16:149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59f761111defb04d91eb123d44c75951
https://doi.org/10.1097/00002371-199408000-00013
https://doi.org/10.1097/00002371-199408000-00013